Dear Shareholders,
Greetings of the day!
I am writing this letter to inform you and bring to your notice about
two important events:
1. Our company has become profitable.
2. We have initiated the regulatory process to simplify our corporate
structure.
Detailed presentations regarding our performance and the changes in our
corporate structure have been uploaded to the company's website and the stock exchange.
We are committed to building a long-term business that offers a
data-driven, digital supply chain for pharmaceuticals, diagnostics and wellness in India,
catering to both B2B and B2C spaces.
In this decade of India's growth, there are ample opportunities to
transform the way we do our business in India.
India currently has more than 600 million smartphone users, a number
which is expected to grow over time as more feature phone users migrate to smartphones,
therefore digital is going to be the mainstream for delivery of services.
We are dedicated to developing an ecosystem that fosters growth and
ensures sustainable cash flow.
Artificial Intelligence (AI) is set to play a pivotal role in
healthcare due to its ability to scale intellectual output and expedite processes. Our
team is actively working on innovative AI-powered delivery applications.
With a portion of India's young population entering an ageing
demographic and having disposable income, healthcare spending is expected to rise.
Furthermore, government health expenditure, as a part of social welfare, is expected to
increase.
We see a very bright future of healthcare in India fuelled by digital
technology's capacity to scale, improved efficiency, and excellence.
With Best Regards,
B.L. Mittal
Chairman & Managing Director